The IPO wave kept rolling for venture-capital-backed biotech as two life science companies held their first trading day Friday, while another estimated a price range for its public debut and a fourth publicly filed its paperwork.
Reuters Shares of Aquinox Pharmaceuticals Inc. rose 8.6%, while Recro Pharma Inc.‘s stock rose 3.8%.
{iframe}http://blogs.wsj.com/venturecapital/2014/03/07/biotech-ipo-march-continues-aquinox-and-recro-rise/?mod=WSJBlog{/iframe}